Evidence map›Paper›PMID 41971189›Full record

ReviewNeuroethics2026

The Enduring Promise of Personalising Patient Preference Prediction.

Brian D Earp, Sebastian Porsdam Mann, Tessa van Veenendaal, Jemima Allen, Sabine Salloch, Karin Jongsma, Matthias Braun, Walter Sinnott-Armstrong, Julian Savulescu, David Wendler and 1 more

Abstract readReview
In one paragraph

Review in Neuroethics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Brian D EarpCentre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Sebastian Porsdam MannCentre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Tessa van VeenendaalUehiro Oxford Institute, University of Oxford, Oxford, United Kingdom.
Jemima AllenUehiro Oxford Institute, University of Oxford, Oxford, United Kingdom.
Sabine SallochInstitute for Ethics, History and Philosophy of Medicine, Hannover Medical School, Hanover, Germany.
Karin JongsmaJulius Center, University Medical Center Utrecht, Utrecht, Netherlands.
Matthias BraunUehiro Oxford Institute, University of Oxford, Oxford, United Kingdom.
Walter Sinnott-ArmstrongDepartment of Philosophy and the Kenan Institute for Ethics, Duke University, Durham, USA.
Julian SavulescuCentre for Biomedical Ethics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
David WendlerClinical Center Department of Bioethics, National Institutes of Health, Bethesda, USA.
Annette RidClinical Center Department of Bioethics, National Institutes of Health, Bethesda, USA.

Funding

Wellcome Trust
6 · The paper itself

Abstract

The challenge of making healthcare decisions for incapacitated patients continues to confront stakeholders worldwide. Annette Rid and David Wendler proposed a Patient Preference Predictor (P3) that uses population-level data to infer an incapacitated patient's likely treatment choices, with the aim of aligning care with the values and preferences they held when last autonomous. Some objectors claimed this would fail to respect patients' (former) autonomy because the basis for prediction would not be specific to the individual (e.g., based on data reflecting their own specific reasons for preferring one course of action over another). In response, we proposed a 'Personalised Patient Preference Predictor' (P4) that would harness the predictive capacities of personalised large language models (LLMs) fine-tuned on individual-level data of various kinds. The envisioned P4, if realized, would be akin to a 'digital psychological twin' or AI simulation of the patient that would encode their unique preferences and values to enable an individualised prediction of their likely treatment preferences. The P4, in turn, has been criticised on various grounds: philosophical, practical, and ethical. Here, we comprehensively evaluate the concerns of our critics based on all known published critiques as of the time of writing. While acknowledging the weight of some of these concerns, we argue that they do not entail that a P4 should not be developed. Rather, the concerns point to areas where thoughtful design choices, responsible regulation, and further philosophical reflection are needed to steer the proposal in a positive direction.

Indexed as

Advanced decision makingAutonomyPersonalized patient preference predictorSubstituted judgment

Identifiers

PMID41971189
PMCPMC13068716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.